Also trades as: CBTE (OTC) · $vol 0M
INTI OTC
Inhibitor Therapeutics, Inc.
1W: -2.0%
1M: +10.1%
3M: +24.8%
YTD: +109.0%
1Y: +96.0%
3Y: +188.2%
5Y: -69.4%
$0.10
-0.00 (-2.00%)
Weekly Expected Move ±41.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-3M
Net Income
+4.0% YoY
$-3M
Free Cash Flow
+4.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE358.8%
ROA-145.6%
ROIC88.0%
Valuation
P/E-5.1
P/B-6.6
EV/EBITDA-4.0
Leverage
Debt/Equity-0.02
Current Ratio3.36
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z-138.55
Beneish M0.00